SCG5
Neuroendocrine protein 7B2
Also known as: 7B2, 7B2_HUMAN, SGNE1, SgV
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P05408
- Gene
- SCG5
- Ensembl
- ENSG00000166922
- Chromosome
- 15
- Canonical length
- 212 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a secreted chaperone protein that prevents the aggregation of other secreted proteins, including proteins that are associated with neurodegenerative and metabolic disease. The encoded protein may be best known for its role in the trafficking and activation of prohormone convertase PC2 (encoded by Gene ID: 5126). Phosphorylation of the encoded protein has been shown to have an inhibitory effect on its chaperone function. This gene also produces a ARHGAP11A-SCG5 readthrough transcript and ARHGAP11A-SCG5 protein. [provided by RefSeq, Feb 2019]
Canonical amino-acid sequenceUniProt
212 residues, UniProt reviewed canonical sequence.
>P05408|SCG5
1 MVSRMVSTML SGLLFWLASG WTPAFAYSPR TPDRVSEADI QRLLHGVMEQ LGIARPRVEY
61 PAHQAMNLVG PQSIEGGAHE GLQHLGPFGN IPNIVAELTG DNIPKDFSED QGYPDPPNPC
121 PVGKTADDGC LENTPDTAEF SREFQLHQHL FDPEHDYPGL GKWNKKLLYE KMKGGERRKR
181 RSVNPYLQGQ RLDNVVAKKS VPHFSDEDKD PELocalizationUniProt · AlphaFold · HPA
Whether an antibody against SCG5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 386 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 386 nTPM
- choroid plexus: 347 nTPM
- cerebral cortex: 246 nTPM
- basal ganglia: 213 nTPM
- cerebellum: 185 nTPM
- hypothalamus: 183 nTPM
Single-cell type
- other brain neurons: 179 nCPM
- brain inhibitory neurons: 157 nCPM
- brain excitatory neurons: 125 nCPM
- oligodendrocytes: 90 nCPM
- oligodendrocyte progenitor cells: 69 nCPM
- choroid plexus epithelial cells: 38 nCPM
Immune cell
- memory CD4 T-cell: 0.3 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- hypothalamus: 131 nTPM
- cerebral cortex: 130 nTPM
- choroid plexus: 128 nTPM
- basal ganglia: 83 nTPM
- hippocampal formation: 77 nTPM
- spinal cord: 77 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SCG5.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 65 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Disease | ImmuneIEDB
Conditions an epitope on SCG5 was assayed in.
- type 1 diabetes mellitus T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.22
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.61
- DepMap mean gene effect
- -0.35
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular protein transport
- neuropeptide signaling pathway
- peptide hormone processing
- regulation of hormone secretion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Neuroendocrine 7B2 precursor
- Neuroendocrine protein 7B2 precursor (Secretogranin V)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SCG5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SCG5 as an antibody target. Whether an autoantibody or antibody against SCG5 could matter depends on whether native SCG5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SCG5 is annotated as secreted, so native SCG5 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label SCG5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...